Browsing: Divis Laboratories

By Shrikant Chouhan The benchmark indices bounced again sharply, the NSE Nifty 50 ended 289 factors increased and the BSE…

Divi’s Laboratories’ (Divi’s) Q4FY22 efficiency beat our estimates throughout parameters. Consolidated revenues grew 40.8% y-o-y to Rs 25.2 bn, Ebitda…

Domestic inventory markets had been shifting between beneficial properties and losses on Tuesday as volatility zoomed previous 25 ranges. S&P…

Domestic benchmark indices Sensex and Nifty had seen a spectacular rise a trading day ago, but today the sell-off in…

Markets closed higher for the first two days of the week but were seen trading choppy trade for the next…

By keeping a close watch on every movement of stocks, your investment can definitely be protected. Here we are telling…